These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26881468)

  • 1. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes.
    Kucharz EJ; Kovalenko V; Szántó S; Bruyère O; Cooper C; Reginster JY
    Curr Med Res Opin; 2016 Jun; 32(6):997-1004. PubMed ID: 26881468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment.
    Saengnipanthkul S; Waikakul S; Rojanasthien S; Totemchokchyakarn K; Srinkapaibulaya A; Cheh Chin T; Mai Hong N; Bruyère O; Cooper C; Reginster JY; Lwin M
    Int J Rheum Dis; 2019 Mar; 22(3):376-385. PubMed ID: 28332780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
    Bruyère O; Altman RD; Reginster JY
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S12-7. PubMed ID: 26806187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting.
    Bruyère O; Cooper C; Pelletier JP; Maheu E; Rannou F; Branco J; Luisa Brandi M; Kanis JA; Altman RD; Hochberg MC; Martel-Pelletier J; Reginster JY
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S3-11. PubMed ID: 26806188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Bruyère O; Cooper C; Al-Daghri NM; Dennison EM; Rizzoli R; Reginster JY
    Aging Clin Exp Res; 2018 Feb; 30(2):111-117. PubMed ID: 29177637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.
    Rovati LC; Girolami F; D'Amato M; Giacovelli G
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S34-41. PubMed ID: 26632505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint.
    Zhang Z; Huang C; Cao Y; Mu R; Zhang MC; Xing D; Fan D; Ding Y; Guo J; Hou Y; Jianhao L; Veronese N; Reginster JY; Bruyere O; Cavalier E; Zhang H
    Aging Clin Exp Res; 2021 Aug; 33(8):2141-2147. PubMed ID: 34189714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.
    Bernetti A; Mangone M; Villani C; Alviti F; Valeo M; Grassi MC; Migliore A; Viora U; Adriani E; Quirino N; Fioravanti A; Paoloni M
    Eur J Phys Rehabil Med; 2019 Oct; 55(5):658-664. PubMed ID: 31106560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Assessment of Different Glucosamines in Patients with Knee Osteoarthritis: A Simulation Model Adapted to Germany.
    Bruyère O; Detilleux J; Reginster JY
    Curr Aging Sci; 2021; 14(3):242-248. PubMed ID: 33858318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
    Gregori D; Giacovelli G; Minto C; Barbetta B; Gualtieri F; Azzolina D; Vaghi P; Rovati LC
    JAMA; 2018 Dec; 320(24):2564-2579. PubMed ID: 30575881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on recent therapeutic guidelines for osteoarthritis.
    Cutolo M; Berenbaum F; Hochberg M; Punzi L; Reginster JY
    Semin Arthritis Rheum; 2015 Jun; 44(6):611-7. PubMed ID: 25677861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current role of glucosamine in the treatment of osteoarthritis.
    Reginster JY; Bruyere O; Neuprez A
    Rheumatology (Oxford); 2007 May; 46(5):731-5. PubMed ID: 17401134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis.
    Bruyere O; Reginster JY
    Drugs Aging; 2007; 24(7):573-80. PubMed ID: 17658908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2019 revised algorithm for the management of knee osteoarthritis: the Southeast Asian viewpoint.
    Yeap SS; Tanavalee A; Perez EC; Tan MP; Reyes BHM; Lee JK; Norhamdan MY; Vista ES; Chan WS; Cong SB; Tam PTT; Kaufman JM; Reginster JY; Veronese N; Penserga E
    Aging Clin Exp Res; 2021 May; 33(5):1149-1156. PubMed ID: 33774784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of functional performance outcomes between oral patented crystalline glucosamine sulfate and platelet-rich plasma among knee osteoarthritis patients: a propensity score matching analysis.
    Amarase C; Tanavalee A; Ngarmukos S; Tanavalee C; Jaruthien N; Somrak P; Tantavisut S
    Aging Clin Exp Res; 2024 Aug; 36(1):168. PubMed ID: 39126538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis.
    Kucharz EJ; Szántó S; Ivanova Goycheva M; Petronijević M; Šimnovec K; Domżalski M; Gallelli L; Kamenov Z; Konstantynowicz J; Radunović G; Šteňo B; Stoilov R; Stok R; Vrana R; Bruyère O; Cooper C; Reginster JY
    Rheumatol Int; 2019 Jul; 39(7):1117-1123. PubMed ID: 31129712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis.
    Rabade A; Viswanatha GL; Nandakumar K; Kishore A
    Inflammopharmacology; 2024 Jun; 32(3):1759-1775. PubMed ID: 38581640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible synergic action of non-steroidal anti-inflammatory drugs and glucosamine sulfate for the treatment of knee osteoarthritis: a scoping review.
    Veronese N; Ecarnot F; Cheleschi S; Fioravanti A; Maggi S
    BMC Musculoskelet Disord; 2022 Dec; 23(1):1084. PubMed ID: 36510167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Management of Osteoarthritis With a Focus on Symptomatic Slow-Acting Drugs: Recommendations From Leading Russian Experts.
    Alexander LAM; Ln D; Eg Z; Is D; Ay K; Ss R; Ea T; Sp Y; Ez Y; L G
    J Clin Rheumatol; 2021 Dec; 27(8):e533-e539. PubMed ID: 32732520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.